Dr Chodak discusses multiparametric MRI versus biopsy in active surveillance of men with prostate cancer.

Dr Chodak discusses proposed USPSTF prostate cancer screening guidelines and offers much needed education for patients on the pros and cons of screening.

Dr Gerald Chodak discusses the clinical implications of new data on recurrence patterns in prostate cancer patients following radical prostatectomy.

Dr Chodak explores several unanswered questions posed by a multicenter analysis comparing treatments in more than 1000 advanced prostate cancer patients.

Dr Chodak discusses the next steps for prostate cancer patients following a negative initial biopsy, based on 20 years of data analyzed in a recent population-based study of prostate cancer mortality risk.

The just-released Testosterone Trials provide more information on screening for or treating low T. Should family physicians intervene in older men?

Initial study results using photodynamic therapy for shrinking prostate cancer size are promising and demonstrate the need for studies with longer follow-up and larger study groups.

While the FDA and AUA slightly differ on their fluoroquinolone safety warnings for prostate biopsy, Dr Gerald Chodak advises against its use due to the possible severe side effects.

Dr Chodak reviews a new algorithm intended to simplify PSA testing. But is it ready for prime time?

Eric Topol speaks with Adam Gazzaley, a neuroscientist studying the therapeutic potential of video games to treat a number of brain diseases and mental disorders.